www.chinaservicesinfo.com

News

21 COVID-19 vaccines enter clinical trials in China

Updated: Jun 8, 2021 Xinhua Print
Share - WeChat

BEIJING — China has witnessed 21 COVID-19 vaccines enter clinical trials, an official with the National Health Commission (NHC) said on June 6.

So far, four COVID-19 vaccines have been granted conditional marketing approval and three have been authorized for emergency use within the country, according to Zeng Yixin, deputy head of the NHC.

A total of eight COVID-19 vaccines have been approved for phase III clinical trial overseas, and one messenger RNA (mRNA) COVID-19 vaccine met the ethical requirements for phase III clinical trial overseas, Zeng said.

Copyright©2024 China Daily. All rights reserved.

京ICP备13028878号-6

京公网安备 11010502032503号 京公网安备 11010502032503号